Prialt (ziconotide)
- Region
- 🇪🇺 EU
- Active substance
- ziconotide
- Company
- Esteve Pharmaceuticals GmbH
- Status
- Authorised
- Therapeutic area
- Injections, Spinal; Pain
- CHMP opinion
- Thu 18 Nov 2004
- EU approval
- Mon 21 Feb 2005
- Application
- EMEA/H/C/000551
- ATC
- N02BG08
- Official record
- www.ema.europa.eu
Indication
Ziconotide is indicated for the treatment of severe, chronic pain in patients who require intrathecal (IT) analgesia.
Regulatory milestones
No milestones recorded in the last year.
Follow Prialt
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.